INSIGHTS ON QUALITY ASSURANCE

• Ringing The Alarm: Unified Data For GMP Annex 1 Compliance

  Alarm monitoring can be more than compliance. Learn how unified data and real-time insights helped one pharma company unlock efficiency, predictive analytics, and a path to digital transformation.

• Innovative Technologies To Accelerate Identification Of High-Quality Clones

  Cell line development (CLD) is a process often filled with obstacles that can significantly hinder scientific progress. Watch and learn how to overcome common challenges.

• Choosing 21 CFR Part 11 Software: A Practical Buyer's Guide

  Electronic records require audit trails, two-component signatures, authority checks, and ALCOA+ controls. See how to evaluate Part 11 software, build validation packages, and maintain inspection readiness.

• Accelerating ADC Analytical Method Development Through Platform Innovation

  Leverage a platform-based analytical development strategy to accelerate ADC IND readiness through early CQA identification, reduced development risk, and streamlined progression from development to patients.

• Scalable rAAV9 Production Using Advanced Cell Lines And Bioreactors

  6/15/2026

  Progress in gene therapy manufacturing is being driven by improved cell line performance and scalable bioprocessing. See how high-density growth helps streamline development to larger-scale production.

• Compliance To Confidence: Annex 1 For Small-Batch, High-Value Production

  10/3/2025

  Get strategies for meeting the updated GMP Annex 1 in small-batch aseptic filling. Learn about contamination control, quality management, and equipment design for high-value liquid and powder products.

• How To Achieve Right-First-Time Manufacturing

  1/21/2026

  Modernizing QC requires more than isolated fixes. Discover how cloud-based platforms unify systems, automate workflows, and improve data access to help labs reduce cycle times and minimize rework.

• Utilizing A Stepwise Approach For Nitrosamine Risk Mitigation

  5/15/2025

  Insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.

• Quality Without Compromise: GMP Annex 1 For Sterile Manufacturing

  2/4/2025

  Annex 1 sets EU regulatory standards for sterile manufacturing, which emphasize contamination control, quality management, and risk prevention to enhance patient safety and regulatory compliance globally.